Načítá se...
Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study
INTRODUCTION: There is evidence that aldosterone plays a role in the pathogenesis of vascular calcification. The aim of this study was to evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, on the progression of coronary calcification (CC) in peritoneal dialysis patients...
Uloženo v:
| Vydáno v: | J Bras Nefrol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sociedade Brasileira de Nefrologia
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788848/ https://ncbi.nlm.nih.gov/pubmed/31419271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/2175-8239-JBN-2019-0009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|